ProfileGDS4132 / 202315_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 32% 33% 32% 30% 29% 31% 30% 30% 51% 31% 31% 34% 35% 35% 29% 29% 32% 49% 42% 31% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10180.285932
GSM201543Muscle PCOS pioglitazone 12172.368733
GSM201544Muscle PCOS pioglitazone 16180.997232
GSM201545Muscle PCOS pioglitazone 20181.780330
GSM201829Muscle PCOS pioglitazone 23174.923529
GSM201830Muscle PCOS pioglitazon 25179.472931
GSM201831Muscle PCOS pioglitazone 27172.581230
GSM201832Muscle PCOS pioglitazone 3175.51930
GSM201833Muscle PCOS pioglitazone 41127.44951
GSM201834Muscle PCOS pioglitazone 8173.37931
GSM201835Muscle PCOS after pioglitazone 10262.689431
GSM201836Muscle PCOS after pioglitazone 12273.830834
GSM201837Muscle PCOS after pioglitazone 16273.354335
GSM201838Muscle PCOS after pioglitazone 20280.026235
GSM201839Muscle PCOS after pioglitazone 23263.561629
GSM201840Muscle PCOS after pioglitazone 25268.386529
GSM201841Muscle PCOS after pioglitazone 27265.235532
GSM201842Muscle PCOS after pioglitazone 32108.54349
GSM201843Muscle PCOS after pioglitazone 42105.93542
GSM201844Muscle PCOS after pioglitazone 8271.724931